Literature DB >> 25098834

Appetite regulatory hormones in women with anorexia nervosa: binge-eating/purging versus restricting type.

Kamryn T Eddy1, Elizabeth A Lawson, Christina Meade, Erinne Meenaghan, Sarah E Horton, Madhusmita Misra, Anne Klibanski, Karen K Miller.   

Abstract

OBJECTIVE: Anorexia nervosa is a psychiatric illness characterized by low weight, disordered eating, and hallmark neuroendocrine dysfunction. Behavioral phenotypes are defined by predominant restriction or bingeing/purging; binge-eating/purging type anorexia nervosa is associated with poorer outcome. The pathophysiology underlying anorexia nervosa types is unknown, but altered hormones, known to be involved in eating behaviors, may play a role.
METHOD: To examine the role of anorexigenic hormones in anorexia nervosa subtypes, we examined serum levels of peptide YY (PYY; total and active [3-36] forms), brain-derived neurotrophic factor (BDNF), and leptin as primary outcomes in women with DSM-5 restricting type anorexia nervosa (n = 50), binge-eating/purging type anorexia nervosa (n = 25), and healthy controls (n = 22). In addition, women completed validated secondary outcome measures of eating disorder psychopathology (Eating Disorder Examination-Questionnaire) and depression and anxiety symptoms (Hamilton Rating Scales for Depression [HDRS] and Anxiety [HARS]). The study samples were collected from May 22, 2004, to February 7, 2012.
RESULTS: Mean PYY 3-36 and leptin levels were lower and BDNF levels higher in binge-eating/purging type anorexia nervosa than in restricting type anorexia nervosa (all P values < .05). After controlling for body mass index, differences in PYY and PYY 3-36 between anorexia nervosa types were significant (P < .05) and differences in BDNF were at the trend level (P < .10). PYY 3-36 was positively (r = 0.27, P = .02) and leptin was negatively (r = -0.51, P < .0001) associated with dietary restraint; BDNF was positively associated with frequency of purging (r = 0.21, P = .04); and leptin was negatively associated with frequency of bingeing (r = -0.29, P = .007) and purging (r = -0.31, P = .004).
CONCLUSIONS: Among women with anorexia nervosa, the anorexigenic hormones PYY, BDNF, and leptin are differentially regulated between the restricting and binge/purge types. Whether these hormone pathways play etiologic roles with regard to anorexia nervosa behavioral types or are compensatory merits further study. © Copyright 2015 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25098834      PMCID: PMC4408926          DOI: 10.4088/JCP.13m08753

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  33 in total

Review 1.  Endocrine effects of anorexia nervosa.

Authors:  Karen Klahr Miller
Journal:  Endocrinol Metab Clin North Am       Date:  2013-09       Impact factor: 4.741

Review 2.  A meta-analysis of circulating BDNF concentrations in anorexia nervosa.

Authors:  Marek K Brandys; Martien J H Kas; Annemarie A van Elburg; Iain C Campbell; Roger A H Adan
Journal:  World J Biol Psychiatry       Date:  2011-04-12       Impact factor: 4.132

3.  Incomplete restoration of the secretion of ghrelin and PYY compared to insulin after food ingestion following weight gain in anorexia nervosa.

Authors:  Toshihiro Nakahara; Shinya Kojima; Muneki Tanaka; Daisuke Yasuhara; Toshiro Harada; Ken-ichiro Sagiyama; Tetsuro Muranaga; Nobuathu Nagai; Masamitsu Nakazato; Shin-ichi Nozoe; Tetsuro Naruo; Akio Inui
Journal:  J Psychiatr Res       Date:  2006-10-19       Impact factor: 4.791

Review 4.  Psychometric evaluation of the eating disorder examination and eating disorder examination-questionnaire: a systematic review of the literature.

Authors:  Kelly C Berg; Carol B Peterson; Patricia Frazier; Scott J Crow
Journal:  Int J Eat Disord       Date:  2011-07-08       Impact factor: 4.861

5.  Altered ghrelin and peptide YY responses to meals in bulimia nervosa.

Authors:  Shinya Kojima; Toshihiro Nakahara; Nobuatsu Nagai; Tetsuro Muranaga; Muneki Tanaka; Daisuke Yasuhara; Akinori Masuda; Yukari Date; Hiroaki Ueno; Masamitsu Nakazato; Tetsuro Naruo
Journal:  Clin Endocrinol (Oxf)       Date:  2005-01       Impact factor: 3.478

6.  Longitudinal comparison of anorexia nervosa subtypes.

Authors:  Kamryn T Eddy; Pamela K Keel; David J Dorer; Sherrie S Delinsky; Debra L Franko; David B Herzog
Journal:  Int J Eat Disord       Date:  2002-03       Impact factor: 4.861

7.  Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa.

Authors:  Elizabeth A Lawson; Daniel Donoho; Karen K Miller; Madhusmita Misra; Erinne Meenaghan; Janet Lydecker; Tamara Wexler; David B Herzog; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

Review 8.  Dysfunctions of leptin, ghrelin, BDNF and endocannabinoids in eating disorders: beyond the homeostatic control of food intake.

Authors:  Palmiero Monteleone; Mario Maj
Journal:  Psychoneuroendocrinology       Date:  2013-01-11       Impact factor: 4.905

9.  BDNF regulates eating behavior and locomotor activity in mice.

Authors:  S G Kernie; D J Liebl; L F Parada
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

10.  Critical role for peptide YY in protein-mediated satiation and body-weight regulation.

Authors:  Rachel L Batterham; Helen Heffron; Saloni Kapoor; Joanna E Chivers; Keval Chandarana; Herbert Herzog; Carel W Le Roux; E Louise Thomas; Jimmy D Bell; Dominic J Withers
Journal:  Cell Metab       Date:  2006-09       Impact factor: 27.287

View more
  18 in total

Review 1.  Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin.

Authors:  Laura A Berner; Tiffany A Brown; Jason M Lavender; Emily Lopez; Christina E Wierenga; Walter H Kaye
Journal:  Mol Cell Endocrinol       Date:  2018-11-02       Impact factor: 4.102

Review 2.  Examining weight suppression as a transdiagnostic factor influencing illness trajectory in bulimic eating disorders.

Authors:  Pamela K Keel; Lindsay P Bodell; K Jean Forney; Jonathan Appelbaum; Diana Williams
Journal:  Physiol Behav       Date:  2019-05-30

3.  Increased plasma asprosin levels in patients with drug-naive anorexia nervosa.

Authors:  Yanran Hu; Yixiang Xu; Yuchen Zheng; Qing Kang; Zhongze Lou; Qiang Liu; Han Chen; Yunxin Ji; Lei Guo; Chen Chen; Liemin Ruan; Jue Chen
Journal:  Eat Weight Disord       Date:  2020-02-05       Impact factor: 4.652

4.  Leptin secretory dynamics and associated disordered eating psychopathology across the weight spectrum.

Authors:  Charumathi Baskaran; Kamryn T Eddy; Karen K Miller; Erinne Meenaghan; Madhusmita Misra; Elizabeth A Lawson
Journal:  Eur J Endocrinol       Date:  2016-04       Impact factor: 6.664

5.  Changes in appetite-regulating hormones following food intake are associated with changes in reported appetite and a measure of hedonic eating in girls and young women with anorexia nervosa.

Authors:  Christopher Mancuso; Alyssa Izquierdo; Meghan Slattery; Kendra R Becker; Franziska Plessow; Jennifer J Thomas; Kamryn T Eddy; Elizabeth A Lawson; Madhusmita Misra
Journal:  Psychoneuroendocrinology       Date:  2019-12-23       Impact factor: 4.905

6.  Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum.

Authors:  Laura E Dichtel; Elizabeth A Lawson; Melanie Schorr; Erinne Meenaghan; Margaret Lederfine Paskal; Kamryn T Eddy; Graziano Pinna; Marianela Nelson; Ann M Rasmusson; Anne Klibanski; Karen K Miller
Journal:  Neuropsychopharmacology       Date:  2017-11-01       Impact factor: 7.853

7.  Bone density, body composition, and psychopathology of anorexia nervosa spectrum disorders in DSM-IV vs DSM-5.

Authors:  Melanie Schorr; Jennifer J Thomas; Kamryn T Eddy; Laura E Dichtel; Elizabeth A Lawson; Erinne Meenaghan; Margaret Lederfine Paskal; Pouneh K Fazeli; Alexander T Faje; Madhusmita Misra; Anne Klibanski; Karen K Miller
Journal:  Int J Eat Disord       Date:  2016-08-16       Impact factor: 4.861

Review 8.  Gastrointestinal peptides in eating-related disorders.

Authors:  Kimberly R Smith; Timothy H Moran
Journal:  Physiol Behav       Date:  2021-05-11

9.  Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index.

Authors:  A Hinney; M Kesselmeier; S Jall; A-L Volckmar; M Föcker; J Antel; I M Heid; T W Winkler; S F A Grant; Y Guo; A W Bergen; W Kaye; W Berrettini; H Hakonarson; B Herpertz-Dahlmann; M de Zwaan; W Herzog; S Ehrlich; S Zipfel; K M Egberts; R Adan; M Brandys; A van Elburg; V Boraska Perica; C S Franklin; M H Tschöp; E Zeggini; C M Bulik; D Collier; A Scherag; T D Müller; J Hebebrand
Journal:  Mol Psychiatry       Date:  2016-05-17       Impact factor: 13.437

10.  Ghrelin and PYY in low-weight females with avoidant/restrictive food intake disorder compared to anorexia nervosa and healthy controls.

Authors:  Kendra R Becker; Christopher Mancuso; Melissa J Dreier; Elisa Asanza; Lauren Breithaupt; Meghan Slattery; Franziska Plessow; Nadia Micali; Jennifer J Thomas; Kamryn T Eddy; Madhusmita Misra; Elizabeth A Lawson
Journal:  Psychoneuroendocrinology       Date:  2021-04-28       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.